Eur Rev Med Pharmacol Sci 2015; 19 (14): 2521-2522

Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma

M. Berretta, R. Di Francia, U. Tirelli

Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy. mberretta@cro.it

Free PDF Download

To cite this article

M. Berretta, R. Di Francia, U. Tirelli
Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma

Eur Rev Med Pharmacol Sci
Year: 2015
Vol. 19 - N. 14
Pages: 2521-2522

Keywords Related articles:

  1. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma
  2. Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors
  3. Comment on: Short-term effect of metronomic chemotherapy of low dose Tegafur on patients with primary hepatic carcinoma after radiofrequency ablation
  4. Sorafenib in combination with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis
  5. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1